Cogstate Limited (CGS.AX)

1,7000 -0,0750 (-4,23%) Börsenschluss: 04:11PM AEST

Cogstate Limited

425 Smith Street
Suite 117
Fitzroy, VIC 3065
Australia
61 3 9664 1300
https://www.cogstate.com

Sektor(en): Healthcare
Branche: Health Information Services
Vollzeitmitarbeiter: 170

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Bradley O'Connor C.A., B.Bus, CA	CEO, MD & Exec. Director	949,49k	N/A	N/A
Prof. Paul Maruff BBSc (Hons), Ph.D.	Founder & Chief Innovation Officer	566,2k	N/A	N/A
Mr. Darren Watson	Chief Financial Officer	371,24k	N/A	N/A
Mr. Benjamin Bloomfield	Chief Technology Officer	380,83k	N/A	N/A
Mr. Kenneth Billard	Chief Commercial Officer	592,61k	N/A	N/A
Dr. Chris Edgar Ph.D.	Chief Science Officer	N/A	N/A	N/A
Ms. Rachel Colite	VP of Strategic Initiatives, Communication & People	N/A	N/A	N/A
Mr. David James Franks B.Ec, BEc, CA, F Fin, JP.	Company Sec.	N/A	N/A	1970
Dr. Amy E. Veroff Ph.D.	Principal Consultant	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. As of June 30, 2021, it had participated in approximately 1,800 academic research studies in approximately 200 indications. Cogstate Limited was incorporated in 1999 and is based in Fitzroy, Australia.

Corporate Governance

Cogstate Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.